(Q37926572)

English

Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings (English)

1 reference

Europe PubMed Central

25 August 2017

0 references

glucose monitoring

1 reference

based on heuristic

inferred from title

author name string

Sandra L Tunis

1

1 reference

Europe PubMed Central

25 August 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

25 August 2017

Applied Health Economics and Health Policy

1 reference

Europe PubMed Central

25 August 2017

9

1 reference

Europe PubMed Central

25 August 2017

6

1 reference

Europe PubMed Central

25 August 2017

351-365

1 reference

Europe PubMed Central

25 August 2017

https://scigraph.springernature.com/pub.10.2165/11594270-000000000-00000

0 references

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Cost of managing an episode of relapse in multiple sclerosis in the United States

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Consensus report of the coalition for clinical research-self-monitoring of blood glucose

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story?

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Longitudinal study of new and prevalent use of self-monitoring of blood glucose

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Diabetes Care: Making a Good Journal Better.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in type 2 diabetes: systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Treatment intensification in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in overweight type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Preference-Based EQ-5D index scores for chronic conditions in the United States

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

The impact of clinical trial design on cost-effectiveness analyses: illustration from a published study of the one-touch ultrasmart blood glucose meter for insulin-using diabetes patients

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Home blood glucose monitoring in type 2 diabetes: broken health care system undermines study's impact

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Understanding the determinants of health for people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11594270-000000000-00000

21 January 2018

Identifiers

10.2165/11594270-000000000-00000

1 reference

Europe PubMed Central

25 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37926572&oldid=2088611166"